Assay come, assay go: Corporate takeover leads to retraction of device analysis

A group of hematology researchers in Canada lost a publication to the merger of two medical device makers, after the acquiring company apparently decided not to pursue marketing the product in question.

An April 23 retraction notice in the International Journal of Laboratory Hematology about the article, “Enhanced flagging and improved clinical sensitivity on the new DxH 300TM Coulter® cellular analysis system,” originally published in February, tells the tale: Continue reading Assay come, assay go: Corporate takeover leads to retraction of device analysis